GCG and metabolic dysfunction-associated steatotic liver disease: In line with this hypothesis, results from our group show that individuals with NAFLD (both normoglycemic individuals and patients with T2D) exhibit significantly higher fasting plasma glucagon levels compared to matched controls without NAFLD (28).